These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 1403784
1. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13. Strobl JS, Peterson VA. J Pharmacol Exp Ther; 1992 Oct; 263(1):186-93. PubMed ID: 1403784 [Abstract] [Full Text] [Related]
2. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF. Cancer Res; 1990 Sep 01; 50(17):5399-405. PubMed ID: 2386945 [Abstract] [Full Text] [Related]
3. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Reddel RR, Murphy LC, Hall RE, Sutherland RL. Cancer Res; 1985 Apr 01; 45(4):1525-31. PubMed ID: 3978620 [Abstract] [Full Text] [Related]
4. A survey of human breast cancer sensitivity to growth inhibition by calmodulin antagonists in tissue culture. Strobl JS, Peterson VA, Woodfork KA. Biochem Pharmacol; 1994 Jun 15; 47(12):2157-61. PubMed ID: 8031308 [Abstract] [Full Text] [Related]
5. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E, Day BW. Anticancer Res; 1996 Jun 15; 16(3A):1107-15. PubMed ID: 8702221 [Abstract] [Full Text] [Related]
10. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Kremmer T, Pälyi I, Daubner D, Boldizsár M, Vincze B, Paulik E, Sugár J, Pokorny E, Túry E. Anticancer Res; 1991 Jun 15; 11(5):1807-13. PubMed ID: 1768053 [Abstract] [Full Text] [Related]
13. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines. Pihie AH, Stanslas J, Din LB. Anticancer Res; 1998 Jun 15; 18(3A):1739-43. PubMed ID: 9673398 [Abstract] [Full Text] [Related]
15. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA, Lippman ME, Katzenellenbogen BS. Cancer Res; 1984 Nov 15; 44(11):5038-45. PubMed ID: 6488162 [Abstract] [Full Text] [Related]
16. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J. Breast Cancer Res Treat; 2007 Aug 15; 104(2):165-79. PubMed ID: 17061041 [Abstract] [Full Text] [Related]
17. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin. ter Haar E, Hamel E, Balachandran R, Day BW. Anticancer Res; 1997 Aug 15; 17(3C):1861-9. PubMed ID: 9216636 [Abstract] [Full Text] [Related]
18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749 [Abstract] [Full Text] [Related]